| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00004850-200015060-00001 |
| P698 | PubMed publication ID | 11110006 |
| P2093 | author name string | I Hindmarch | |
| S Kimber | |||
| S M Cockle | |||
| P433 | issue | 6 | |
| P304 | page(s) | 305-318 | |
| P577 | publication date | 2000-11-01 | |
| P1433 | published in | International Clinical Psychopharmacology | Q15751307 |
| P1476 | title | Abrupt and brief discontinuation of antidepressant treatment: effects on cognitive function and psychomotor performance | |
| P478 | volume | 15 |
| Q35977716 | A case report of onset of tinnitus following discontinuation of antidepressant and a review of the literature |
| Q37254077 | A pilot study of the pharmacodynamic impact of SSRI drug selection and beta-1 receptor genotype (ADRB1) on cardiac vital signs in depressed patients: a novel pharmacogenetic approach. |
| Q22305782 | A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation |
| Q37587159 | Agomelatine: innovative pharmacological approach in depression |
| Q91751261 | Antidepressant Withdrawal and Rebound Phenomena |
| Q24202141 | Citalopram versus other anti-depressive agents for depression |
| Q92897506 | Cognitive Dysfunction in Major Depressive Disorder: Assessment, Impact, and Management |
| Q43955330 | Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: a clinical investigation |
| Q34579202 | Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder |
| Q34118321 | Paroxetine: an update of its use in psychiatric disorders in adults |
| Q52291594 | Pharmacotherapy of mood disorders and treatment discontinuation. |
| Q21129279 | Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved |
| Q37887553 | Specifying the neuropsychology of affective disorders: clinical, demographic and neurobiological factors |
| Q35047546 | Subjective assessment of the effects of CNS-active drugs on sleep by the Leeds sleep evaluation questionnaire: a review |
| Q92234790 | Tapering of SSRI treatment to mitigate withdrawal symptoms |
| Q28211470 | The physiological role of 5-HT2A receptors in working memory |
| Q33989385 | The psychoactive effects of psychiatric medication: the elephant in the room |
| Q33995120 | Tolerability and safety of fluvoxamine and other antidepressants |
Search more.